Patient–doctor engagement in cardiovascular prevention
- 1 August 2019
- journal article
- letter
- Published by Elsevier BV in The Lancet
- Vol. 394 (10199), e26-E26
- https://doi.org/10.1016/s0140-6736(19)31346-7
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trialThe Lancet, 2018
- Improving Hypertension Control in Primary Care With the Measure Accurately, Act Rapidly, and Partner With Patients ProtocolHypertension, 2018
- Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trialThe Lancet, 2018
- Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitusDiabetes & Metabolism, 2017